Zoetis Inc., the world's leading animal health company, has raised its quarterly dividend to $0.53 per share, effective March 3, 2026, which reflects its strong financial performance and anticipated revenue growth, projected to reach $10.9 billion by 2028. The company recently completed a $1.75 billion convertible senior notes offering, targeting funds for stock repurchases while navigating a challenging year marked by a 25% drop in share price. Despite this, Zoetis remains positioned for growth with a robust dividend yield of approximately 1.65% and a projected earnings increase of 25.9%.
“Zoetis Inc. · declared that its shareholders would receive · a dividend of $0.53 a share · on March 3”
“Zoetis Inc. · will participate in · the 44th Annual J.P. Morgan Healthcare Conference · January 12, 2026”
“Zoetis · is · the world’s leading animal health company”
“Zoetis · generated revenue of · $9.3 billion · 2024”
“Zoetis · has approximately · 13,800 employees”
“Zoetis · makes a difference in · over 100 countries”
“Zoetis Inc. · completed · offering of 0.25% senior unsecured convertible notes · US$1.75 billion”
“Zoetis · approved · an increase in its quarterly dividend · 6%”
“Zoetis · projects · revenue · $10.9 billion by 2028”
“Zoetis · projects · earnings · $3.2 billion by 2028”
“Zoetis · has · fair value · $169.96”
“Zoetis · has · upside · 38% to its current price”
